Cambridge Antibody Technology

Results: 24



#Item
1CHI’s Phage Display and Recombinant Antibodies Technology Poster, May 16-20, 2005, Cambridge, MA, Royal Sonesta Hotel Novel strategies for assaying recombinant antibody function with high-throughput cell-based assays C

CHI’s Phage Display and Recombinant Antibodies Technology Poster, May 16-20, 2005, Cambridge, MA, Royal Sonesta Hotel Novel strategies for assaying recombinant antibody function with high-throughput cell-based assays C

Add to Reading List

Source URL: www.phynexus.com

Language: English - Date: 2005-05-12 14:55:27
    2High throughput 96-well purification of biopharmaceuticals for cell-based screening Mike Jones, Debbie Pattison, Mark Liddament, John Andrews, Ruth Franks, Caroline Russell, Stephen Clulow Cambridge Antibody Technology,

    High throughput 96-well purification of biopharmaceuticals for cell-based screening Mike Jones, Debbie Pattison, Mark Liddament, John Andrews, Ruth Franks, Caroline Russell, Stephen Clulow Cambridge Antibody Technology,

    Add to Reading List

    Source URL: phynexus.com

    Language: English - Date: 2006-02-22 12:42:56
      3High throughput 96-well purification of biopharmaceuticals for cell-based screening Mike Jones, Debbie Pattison, Mark Liddament, John Andrews, Ruth Franks, Caroline Russell, Stephen Clulow Cambridge Antibody Technology,

      High throughput 96-well purification of biopharmaceuticals for cell-based screening Mike Jones, Debbie Pattison, Mark Liddament, John Andrews, Ruth Franks, Caroline Russell, Stephen Clulow Cambridge Antibody Technology,

      Add to Reading List

      Source URL: www.phynexus.com

      Language: English - Date: 2006-02-22 12:42:56
        4CHI’s Phage Display and Recombinant Antibodies Technology Poster, May 16-20, 2005, Cambridge, MA, Royal Sonesta Hotel Novel strategies for assaying recombinant antibody function with high-throughput cell-based assays C

        CHI’s Phage Display and Recombinant Antibodies Technology Poster, May 16-20, 2005, Cambridge, MA, Royal Sonesta Hotel Novel strategies for assaying recombinant antibody function with high-throughput cell-based assays C

        Add to Reading List

        Source URL: phynexus.com

        Language: English - Date: 2005-05-12 14:55:27
          5Tetragenetics Announces Collaboration with Amgen Exclusive Research License Of Tetragenetics’ Technology For Surface Antigen Drug Target CAMBRIDGE, Mass. April 2, 2013. Tetragenetics Inc. a 2012 Gates Foundation Phase

          Tetragenetics Announces Collaboration with Amgen Exclusive Research License Of Tetragenetics’ Technology For Surface Antigen Drug Target CAMBRIDGE, Mass. April 2, 2013. Tetragenetics Inc. a 2012 Gates Foundation Phase

          Add to Reading List

          Source URL: www.tetragenetics.com

          Language: English - Date: 2013-03-30 23:57:21
          6  	
   	
     	
   	
  

                     

          Add to Reading List

          Source URL: www.humabs.com

          Language: English - Date: 2015-05-18 04:26:45
          7p06 FAW01 - A4 RGB Version

          p06 FAW01 - A4 RGB Version

          Add to Reading List

          Source URL: www.callfortargets.org

          Language: English - Date: 2013-08-06 10:18:21
          8FOR	
  IMMEDIATE	
  RELEASE	
   	
   Theraclone	
  Sciences’	
  I-­‐STAR™	
  Technology	
  Chosen	
  by	
  Wellcome	
  Trust	
  	
   to	
  Identify	
  Therapeutic	
  Antibodies	
  Against	
  Ebol

          FOR  IMMEDIATE  RELEASE     Theraclone  Sciences’  I-­‐STAR™  Technology  Chosen  by  Wellcome  Trust     to  Identify  Therapeutic  Antibodies  Against  Ebol

          Add to Reading List

          Source URL: www.theraclone-sciences.com

          Language: English - Date: 2015-04-30 08:07:06
          9Immune system / Medicine / Monoclonal antibodies / Crucell / Biologic / Polyclonal antibodies / Cambridge Antibody Technology / Mogamulizumab / Biology / Immunology / Biotechnology

          Press Release: Bioceros - through its affiliated company BiocerOX Products and Janssen execute agreement to develop a monoclonal antibody. Utrecht, The Netherlands, January 8, 2014 Dutch Biotech company Bioceros today an

          Add to Reading List

          Source URL: www.bioceros.com

          Language: English - Date: 2014-01-08 02:14:10
          10Kymab and the Wellcome Trust initiate Ebola Project Drug discovery partnership to produce an antibody-based medicine to fight Ebola infection Kymab is leading a consortium which includes the University of Westminster, th

          Kymab and the Wellcome Trust initiate Ebola Project Drug discovery partnership to produce an antibody-based medicine to fight Ebola infection Kymab is leading a consortium which includes the University of Westminster, th

          Add to Reading List

          Source URL: www.kymab.com

          Language: English - Date: 2014-12-15 11:47:17